Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Pyruvate Dehydrogenase Kinase Is a Metabolic Checkpoint for Polarization of Macrophages to the M1 Phenotype.

Min BK, Park S, Kang HJ, Kim DW, Ham HJ, Ha CM, Choi BJ, Lee JY, Oh CJ, Yoo EK, Kim HE, Kim BG, Jeon JH, Hyeon DY, Hwang D, Kim YH, Lee CH, Lee T, Kim JW, Choi YK, Park KG, Chawla A, Lee J, Harris RA, Lee IK.

Front Immunol. 2019 May 7;10:944. doi: 10.3389/fimmu.2019.00944. eCollection 2019.

2.

Simultaneous left and right ventricular apical thrombi after occlusion of the wrapped left anterior descending artery.

Kim BG, Kim KH, Nah JC, Cho SW.

J Cardiol Cases. 2019 Feb 13;19(5):153-156. doi: 10.1016/j.jccase.2018.12.015. eCollection 2019 May.

3.

Transcatheter aortic valve replacement in a patient with anomalous origin of the left coronary artery.

Cho SW, Kim BG, Park TK, Choi SH, Gwon HC, Park SJ, Nah JC.

J Cardiol Cases. 2019 Feb 10;19(4):133-135. doi: 10.1016/j.jccase.2018.12.011. eCollection 2019 Apr.

4.

Impact of lenalidomide on collected hematopoietic myeloid and erythroid progenitors: peripheral stem cell collection may not be affected.

Dosani T, Covut F, Pinto R, Kim BG, Ali N, Beck R, Maitta R, Downes K, Fox R, Reese J, de Lima M, Malek E.

Leuk Lymphoma. 2019 Mar 7:1-8. doi: 10.1080/10428194.2019.1573367. [Epub ahead of print]

PMID:
30845862
5.

The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ.

Lee JM, Choi SS, Lee YH, Khim KW, Yoon S, Kim BG, Nam D, Suh PG, Myung K, Choi JH.

Exp Mol Med. 2018 Oct 15;50(10):135. doi: 10.1038/s12276-018-0162-6.

6.

The chromatin remodeler RSF1 controls centromeric histone modifications to coordinate chromosome segregation.

Lee HS, Lin Z, Chae S, Yoo YS, Kim BG, Lee Y, Johnson JL, Kim YS, Cantley LC, Lee CW, Yu H, Cho H.

Nat Commun. 2018 Sep 21;9(1):3848. doi: 10.1038/s41467-018-06377-w.

7.

Association between body mass index and clinical outcomes after new-generation drug-eluting stent implantation: Korean multi-center registry data.

Kim BG, Hong SJ, Kim BK, Ahn CM, Shin DH, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.

Atherosclerosis. 2018 Oct;277:155-162. doi: 10.1016/j.atherosclerosis.2018.08.047. Epub 2018 Aug 31.

PMID:
30216914
8.

PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels.

Park BY, Jeon JH, Go Y, Ham HJ, Kim JE, Yoo EK, Kwon WH, Jeoung NH, Jeon YH, Koo SH, Kim BG, He L, Park KG, Harris RA, Lee IK.

Diabetes. 2018 Oct;67(10):2054-2068. doi: 10.2337/db17-1529. Epub 2018 Jul 31.

9.

The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B.

Kim BG, Park NH, Lee SB, Jeon S, Park JH, Jung SW, Jeong ID, Bang SJ, Shin JW.

Liver Int. 2018 Dec;38(12):2269-2276. doi: 10.1111/liv.13938. Epub 2018 Aug 19.

PMID:
30052303
10.

Mortality, liver transplantation and hepatic complications in patients with treatment-naïve chronic hepatitis B treated with entecavir vs tenofovir.

Kim BG, Park NH, Lee SB, Lee H, Lee BU, Park JH, Jung SW, Jeong ID, Bang SJ, Shin JW.

J Viral Hepat. 2018 Dec;25(12):1565-1575. doi: 10.1111/jvh.12971. Epub 2018 Aug 14.

PMID:
29998592
11.

Silent invasion of Hem-O-Lok clip.

Park DJ, Kim BG, Jeong ID, Kim GY.

Ann Surg Treat Res. 2018 Mar;94(3):159-161. doi: 10.4174/astr.2018.94.3.159. Epub 2018 Feb 28.

12.

Impact of peripheral artery disease on early and late outcomes of transcatheter aortic valve implantation in patients with severe aortic valve stenosis.

Kim BG, Ko YG, Hong SJ, Ahn CM, Kim JS, Kim BK, Choi D, Jang Y, Hong MK, Lee SH, Lee S, Chang BC.

Int J Cardiol. 2018 Mar 15;255:206-211. doi: 10.1016/j.ijcard.2017.11.065.

PMID:
29425561
13.

Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.

Lee SB, Park GM, Lee JY, Lee BU, Park JH, Kim BG, Jung SW, Jeong ID, Bang SJ, Shin JW, Park NH, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee HC.

J Hepatol. 2018 May;68(5):1018-1024. doi: 10.1016/j.jhep.2017.12.012. Epub 2017 Dec 20.

PMID:
29274406
14.

Multimodality Imaging of Anomalous Left Coronary Artery from the Pulmonary Artery.

Kim BG, Cho SW, Hwang DH, Nah JC.

J Cardiovasc Ultrasound. 2017 Sep;25(3):107-109. doi: 10.4250/jcu.2017.25.3.107. Epub 2017 Sep 29. No abstract available.

15.

A huge thrombosed aneurysm of a saphenous vein graft leading to compression of cardiac structures: role of multimodality imaging.

Kim BG, Kim IC, Kang SM, Youn YN.

J Geriatr Cardiol. 2017 Aug;14(8):536-537. doi: 10.11909/j.issn.1671-5411.2017.08.009. No abstract available.

16.

Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response Rates.

Malek E, Saygin C, Ye R, Covut F, Kim BG, Welge J, Meropol NJ, De Lima M, Driscoll JJ.

JCO Clin Cancer Inform. 2017 Nov;1:1-14. doi: 10.1200/CCI.17.00055. Review.

17.

Potent suppression of both spontaneous and carcinogen-induced colitis-associated colorectal cancer in mice by dietary celastrol supplementation.

Barker EC, Kim BG, Yoon JH, Tochtrop GP, Letterio JJ, Choi SH.

Carcinogenesis. 2018 Jan 12;39(1):36-46. doi: 10.1093/carcin/bgx115.

18.

Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naïve Patients with Chronic Hepatitis B.

Du Jeong I, Jung SW, Park BR, Lee BU, Park JH, Kim BG, Bang SJ, Shin JW, Park NH.

Dig Dis Sci. 2017 Oct;62(10):2908-2914. doi: 10.1007/s10620-017-4737-1. Epub 2017 Sep 4.

PMID:
28871337
19.

Transfer-RNA-mediated enhancement of ribosomal proteins S6 kinases signaling for cell proliferation.

Kwon NH, Lee MR, Kong J, Park SK, Hwang BJ, Kim BG, Lee ES, Moon HG, Kim S.

RNA Biol. 2018;15(4-5):635-648. doi: 10.1080/15476286.2017.1356563. Epub 2018 Feb 1.

20.

PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC.

Kim MJ, Choi YK, Park SY, Jang SY, Lee JY, Ham HJ, Kim BG, Jeon HJ, Kim JH, Kim JG, Lee IK, Park KG.

Mol Cancer Res. 2017 Sep;15(9):1230-1242. doi: 10.1158/1541-7786.MCR-17-0061. Epub 2017 Jun 5.

21.

Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c-SIRT2 axis.

Cha Y, Han MJ, Cha HJ, Zoldan J, Burkart A, Jung JH, Jang Y, Kim CH, Jeong HC, Kim BG, Langer R, Kahn CR, Guarente L, Kim KS.

Nat Cell Biol. 2017 May;19(5):445-456. doi: 10.1038/ncb3517. Epub 2017 Apr 24.

22.

Nedd4 Deficiency in Vascular Smooth Muscle Promotes Vascular Calcification by Stabilizing pSmad1.

Lee JH, Jeon SA, Kim BG, Takeda M, Cho JJ, Kim DI, Kawabe H, Cho JY.

J Bone Miner Res. 2017 May;32(5):927-938. doi: 10.1002/jbmr.3073. Epub 2017 Feb 23.

23.
24.

O-GlcNAcylation of ATG4B positively regulates autophagy by increasing its hydroxylase activity.

Jo YK, Park NY, Park SJ, Kim BG, Shin JH, Jo DS, Bae DJ, Suh YA, Chang JH, Lee EK, Kim SY, Kim JC, Cho DH.

Oncotarget. 2016 Aug 30;7(35):57186-57196. doi: 10.18632/oncotarget.11083.

25.

Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis.

Go Y, Jeong JY, Jeoung NH, Jeon JH, Park BY, Kang HJ, Ha CM, Choi YK, Lee SJ, Ham HJ, Kim BG, Park KG, Park SY, Lee CH, Choi CS, Park TS, Lee WN, Harris RA, Lee IK.

Diabetes. 2016 Oct;65(10):2876-87. doi: 10.2337/db16-0223. Epub 2016 Jul 6.

26.

O-GlcNAcylation of Orphan Nuclear Receptor Estrogen-Related Receptor γ Promotes Hepatic Gluconeogenesis.

Misra J, Kim DK, Jung YS, Kim HB, Kim YH, Yoo EK, Kim BG, Kim S, Lee IK, Harris RA, Kim JS, Lee CH, Cho JW, Choi HS.

Diabetes. 2016 Oct;65(10):2835-48. doi: 10.2337/db15-1523. Epub 2016 Jun 22.

27.

Myeloid-derived suppressor cells: The green light for myeloma immune escape.

Malek E, de Lima M, Letterio JJ, Kim BG, Finke JH, Driscoll JJ, Giralt SA.

Blood Rev. 2016 Sep;30(5):341-8. doi: 10.1016/j.blre.2016.04.002. Epub 2016 Apr 12. Review.

28.

Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.

Park J, Park E, Jung CK, Kang SW, Kim BG, Jung Y, Kim TH, Lim JY, Lee SE, Min CK, Won KA.

BMC Cancer. 2016 Mar 24;16:247. doi: 10.1186/s12885-016-2285-2.

29.

Hemorheological and Glycemic Parameters and HDL Cholesterol for the Prediction of Cardiovascular Events.

Cho SW, Kim BG, Kim BO, Byun YS, Goh CW, Rhee KJ, Kwon HM, Lee BK.

Arq Bras Cardiol. 2016 Jan;106(1):56-61. doi: 10.5935/abc.20150146. Epub 2015 Dec 22. English, Portuguese.

30.

Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma.

Lim SM, Jeong Y, Lee S, Im H, Tae HS, Kim BG, Park HD, Park J, Hong S.

J Med Chem. 2015 Nov 12;58(21):8491-502. doi: 10.1021/acs.jmedchem.5b01415. Epub 2015 Oct 29.

PMID:
26496175
31.

Reduced systemic vascular resistance is the underlying hemodynamic mechanism in nitrate-stimulated vasovagal syncope during head-up tilt-table test.

Kim BG, Cho SW, Lee HY, Kim DH, Byun YS, Goh CW, Rhee KJ, Kim BO.

J Arrhythm. 2015 Aug;31(4):196-200. doi: 10.1016/j.joa.2014.11.008. Epub 2015 Apr 16.

32.

Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex.

Li Y, Kim BG, Qian S, Letterio JJ, Fung JJ, Lu L, Lin F.

J Immunol. 2015 Sep 15;195(6):2648-56. doi: 10.4049/jimmunol.1500139. Epub 2015 Aug 5.

33.

Autocrine Action of Thrombospondin-2 Determines the Chondrogenic Differentiation Potential and Suppresses Hypertrophic Maturation of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.

Jeong SY, Ha J, Lee M, Jin HJ, Kim DH, Choi SJ, Oh W, Yang YS, Kim JS, Kim BG, Chang JH, Cho DH, Jeon HB.

Stem Cells. 2015 Nov;33(11):3291-303. doi: 10.1002/stem.2120. Epub 2015 Aug 25.

34.

Cyclin-dependent kinase 5 represses Foxp3 gene expression and Treg development through specific phosphorylation of Stat3 at Serine 727.

Lam E, Choi SH, Pareek TK, Kim BG, Letterio JJ.

Mol Immunol. 2015 Oct;67(2 Pt B):317-24. doi: 10.1016/j.molimm.2015.06.015. Epub 2015 Jul 19.

35.

Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir.

Kim BG, Jung SW, Kim EH, Kim JH, Park JH, Sung SJ, Park BR, Kim MH, Kim CJ, Lee BU, Park JH, Jeong ID, Bang SJ, Shin JW, Park NH.

J Gastroenterol Hepatol. 2015 Oct;30(10):1514-21. doi: 10.1111/jgh.12993.

PMID:
25973716
36.

Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination.

Park JH, Jung SW, Park NH, Park BR, Kim MH, Kim CJ, Lee BU, Jeong ID, Kim BG, Bang SJ, Shin JW.

Clin Ther. 2015 Jul 1;37(7):1433-42. doi: 10.1016/j.clinthera.2015.04.007. Epub 2015 May 5.

PMID:
25956353
37.

Interactome Analysis Reveals that Heterochromatin Protein 1γ (HP1γ) Is Associated with the DNA Damage Response Pathway.

Kim H, Choi JD, Kim BG, Kang HC, Lee JS.

Cancer Res Treat. 2016 Jan;48(1):322-33. doi: 10.4143/crt.2014.294. Epub 2015 Mar 6.

38.

Prediction of coronary artery disease in patients with lower extremity peripheral artery disease.

Cho SW, Kim BG, Kim DH, Kim BO, Byun YS, Rhee KJ, Lee BK, Goh CW.

Int Heart J. 2015;56(2):209-12. doi: 10.1536/ihj.14-284. Epub 2015 Feb 27.

39.

Stent length is a contributing factor of suboptimal stent expansion in drug-eluting stents.

Kim BG, Cho SW, Kim DH, Kim JH, Byun YS, Goh CW, Rhee KJ, Lee BK, Kim BO.

Kardiol Pol. 2015;73(8):598-605. doi: 10.5603/KP.a2015.0034. Epub 2015 Mar 3.

40.

Three-dimensional echocardiographic views of bicuspid pulmonic valve.

Cho SW, Kim BG, Kim DH, Kim BO, Goh CW, Rhee KJ, Byun YS.

J Cardiovasc Ultrasound. 2014 Sep;22(3):162-3. doi: 10.4250/jcu.2014.22.3.162. Epub 2014 Sep 29. No abstract available.

41.

Promiscuous methionyl-tRNA synthetase mediates adaptive mistranslation to protect cells against oxidative stress.

Lee JY, Kim DG, Kim BG, Yang WS, Hong J, Kang T, Oh YS, Kim KR, Han BW, Hwang BJ, Kang BS, Kang MS, Kim MH, Kwon NH, Kim S.

J Cell Sci. 2014 Oct 1;127(Pt 19):4234-45. doi: 10.1242/jcs.152470. Epub 2014 Aug 5.

42.

Total synthesis of (-)-crinipellin A.

Kang T, Song SB, Kim WY, Kim BG, Lee HY.

J Am Chem Soc. 2014 Jul 23;136(29):10274-6. doi: 10.1021/ja5054412. Epub 2014 Jul 10.

PMID:
25003871
43.

Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.

Choi SH, Kim BG, Robinson J, Fink S, Yan M, Sporn MB, Markowitz SD, Letterio JJ.

J Clin Invest. 2014 Jun;124(6):2472-82. doi: 10.1172/JCI69672. Epub 2014 May 16.

44.

The effectiveness of endoscopic submucosal resection with a ligation device for small rectal carcinoid tumors: focused on previously biopsied tumors.

Im YC, Jung SW, Cha HJ, Yang SS, Kim GY, Yi YA, Park JH, Kim BG, Jeong ID.

Surg Laparosc Endosc Percutan Tech. 2014 Jun;24(3):264-9. doi: 10.1097/SLE.0b013e3182901176.

PMID:
24710234
45.

Autophagy induced by resveratrol suppresses α-MSH-induced melanogenesis.

Kim ES, Chang H, Choi H, Shin JH, Park SJ, Jo YK, Choi ES, Baek SY, Kim BG, Chang JW, Kim JC, Cho DH.

Exp Dermatol. 2014 Mar;23(3):204-6. doi: 10.1111/exd.12337.

PMID:
24499351
46.

Disruption of Smad4 expression in T cells leads to IgA nephropathy-like manifestations.

Inoshita H, Kim BG, Yamashita M, Choi SH, Tomino Y, Letterio JJ, Emancipator SN.

PLoS One. 2013 Nov 4;8(11):e78736. doi: 10.1371/journal.pone.0078736. eCollection 2013.

47.

Effects of collagen tripeptide supplement on skin properties: a prospective, randomized, controlled study.

Choi SY, Ko EJ, Lee YH, Kim BG, Shin HJ, Seo DB, Lee SJ, Kim BJ, Kim MN.

J Cosmet Laser Ther. 2014 Jun;16(3):132-7. doi: 10.3109/14764172.2013.854119. Epub 2013 Nov 18.

PMID:
24131075
48.

Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.

Ahn JM, Sung HJ, Yoon YH, Kim BG, Yang WS, Lee C, Park HM, Kim BJ, Kim BG, Lee SY, An HJ, Cho JY.

Mol Cell Proteomics. 2014 Jan;13(1):30-48. doi: 10.1074/mcp.M113.028621. Epub 2013 Oct 1.

49.

Crystal structure of human cytosolic aspartyl-tRNA synthetase, a component of multi-tRNA synthetase complex.

Kim KR, Park SH, Kim HS, Rhee KH, Kim BG, Kim DG, Park MS, Kim HJ, Kim S, Han BW.

Proteins. 2013 Oct;81(10):1840-6. doi: 10.1002/prot.24306. Epub 2013 Jul 22.

50.

Discovery of a novel class of highly potent, selective, ATP-competitive, and orally bioavailable inhibitors of the mammalian target of rapamycin (mTOR).

Takeuchi CS, Kim BG, Blazey CM, Ma S, Johnson HW, Anand NK, Arcalas A, Baik TG, Buhr CA, Cannoy J, Epshteyn S, Joshi A, Lara K, Lee MS, Wang L, Leahy JW, Nuss JM, Aay N, Aoyama R, Foster P, Lee J, Lehoux I, Munagala N, Plonowski A, Rajan S, Woolfrey J, Yamaguchi K, Lamb P, Miller N.

J Med Chem. 2013 Mar 28;56(6):2218-34. doi: 10.1021/jm3007933. Epub 2013 Mar 7.

PMID:
23394126

Supplemental Content

Loading ...
Support Center